about
Depression of home cage wheel running: a reliable and clinically relevant method to assess migraine pain in rats.Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, U.K.Pilot study of sphenopalatine injection of onabotulinumtoxinA for the treatment of intractable chronic migrainePlacebo effects in neurological diseasesPlacebo and other psychological interactions in headache treatment.Prophylactic onabotulinumtoxinA in patients with chronic migraine and comorbid depression: An open-label, multicenter, pilot study of efficacy, safety and effect on headache-related disability, depression, and anxiety.A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Duliang Soft Capsule in Patients with Chronic Daily HeadacheOnabotulinumtoxinA for chronic migraine: a critical appraisal.Patent Foramen Ovale and Migraine: Closing the Debate--A Review.Does analgesic overuse matter? Response to OnabotulinumtoxinA in patients with chronic migraine with or without medication overuseSafety and efficacy of deep brain stimulation in refractory cluster headache: a randomized placebo-controlled double-blind trial followed by a 1-year open extension.Prevention of episodic migraines with topiramate: results from a non-interventional study in a general practice setting.Does pramipexole treatment improve headache in patients with concomitant migraine and restless legs syndrome?Migraine treatment and placebo effect.Management of chronic daily headache in children.Placebo and nocebo effects in the neurological practice.Brief intervention by general practitioners for medication-overuse headache, follow-up after 6 months: a pragmatic cluster-randomised controlled trial.Onabotulinum toxin A treatment of cervicogenic headache: a randomised, double-blind, placebo-controlled crossover study.What Constitutes an "Adequate" Trial in Migraine Prevention?Is topiramate effective for migraine prevention in patients less than 18 years of age? A meta-analysis of randomized controlled trials.Quality of life and related dimensions in cancer patients treated with mistletoe extract (iscador): a meta-analysisMedium-term effectiveness of online behavioral training in migraine self-management: A randomized trial controlled over 10 months.Telcagepant is a new oral treatment for migraine.Morphometric and volumetric MRI changes in idiopathic intracranial hypertension.Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention: A Randomized Clinical Trial.Levetiracetam in chronic daily headache: a double-blind, randomised placebo-controlled study. (The Australian KEPPRA Headache Trial [AUS-KHT]).OnabotulinumtoxinA: preventive treatment for chronic migraine.Randomized controlled study of telcagepant plus ibuprofen or acetaminophen in migraine.Sphenopalatine Ganglion Block for the Treatment of Acute Migraine Headache.Pain Modulation: From Conditioned Pain Modulation to Placebo and Nocebo Effects in Experimental and Clinical Pain
P2860
Q30365064-577D72BE-B1E6-4391-9315-86047E37A624Q30846961-B3A2B730-D8D0-4897-B72C-5A7E754D28BBQ33572495-96A3867C-427E-4E3A-9306-E4D09591F2CAQ34145218-DF6AC9FC-3BB5-40B2-9438-1FB544F3F579Q34257107-E5A615E6-854E-46F2-8117-8CB5CCDE2F90Q35121186-7AF8DD93-8C79-4629-8D27-CF48C067BFA8Q35697916-326663C8-6062-4A61-82E5-FE96CDD6EDDDQ35822040-DCBD8FBE-5CDA-4ACF-A7B2-04E2C80A2AB0Q35948573-8F274535-5D0C-4CCC-A92F-F89B5416B735Q36234332-5CFA60D7-10FE-4FFE-AACC-AE3B47D00FE4Q36260868-0230E917-A584-4B6B-BFAA-D9C22BA2816BQ36260883-CB6F16CB-2077-4655-8C4C-7D2B68502AD3Q37189782-1634420A-597A-45CA-95DF-CE2BD1262A7AQ37699425-715468D4-8E02-4E6F-A908-CE79C01D84FCQ37785558-D3D21464-0769-4608-9235-3C18F17F6752Q38327044-AFD9A7B1-8D22-40EF-8C23-F29FB2B28DEFQ38398659-87A0D5AA-842D-4838-B1B8-9A44A5929B5BQ38440488-6170730D-6148-40CD-953F-F0E190A256F1Q38585393-840475E8-0F67-4782-934A-2DC2083A3771Q38672931-6E10E286-A0CB-4CD5-9476-17CD1A8BF9C0Q42775521-59B9EFD0-10A4-4153-BEE9-5B75C85AF994Q43633306-B7EFAD31-604B-4815-BFD8-7F7155F4DC63Q45978359-BAE2181F-938A-4392-86AA-916532763FBDQ47231173-EBBAE536-83D3-4C56-9468-744EE393392FQ47677099-573B112D-9BB0-4C66-BA37-144507B89584Q48766624-538E8690-8FD6-41D7-8094-6CEBC6711E87Q49022075-286697C0-4EC4-4D92-8A36-74B1B360A247Q50265031-F9E47B1B-3EF3-4EC8-AEE7-E8B057C8B2F3Q55031304-C1CB92BF-0427-4FB6-917D-4573329114A9Q58779477-5BF9E1EF-4DAC-464F-955A-B68A31121815
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
The importance of placebo in headache research.
@ast
The importance of placebo in headache research.
@en
The importance of placebo in headache research.
@nl
type
label
The importance of placebo in headache research.
@ast
The importance of placebo in headache research.
@en
The importance of placebo in headache research.
@nl
prefLabel
The importance of placebo in headache research.
@ast
The importance of placebo in headache research.
@en
The importance of placebo in headache research.
@nl
P2093
P2860
P1433
P1476
The importance of placebo in headache research.
@en
P2093
P2860
P304
P356
10.1111/J.1468-2982.2008.01660.X
P407
P577
2008-08-22T00:00:00Z